Randomized clinical trial of adjuvant chemotherapy with docetaxel and carboplatin for completely resected stage IB to IIIA non-small cell lung cancer (NSCLC): Preliminary result of Chinese society of lung cancer (CSLC) protocol 0201

被引：0
|
作者：
Yang, X
Wu, Y
Chen, G
Xu, L
Gu, L
Tang, P
Zhu, Y
Xiao, P
Tang, J
Xie, L
机构：
[1] Guangdong Provincial Peoples Hosp, Ctr Canc, Guangzhou, Peoples R China
[2] Guangdong Provincial Peoples Hosp, Lung Canc Res Inst, Guangzhou, Peoples R China
[3] Zhongshan Univ, 3rd Hosp, Guangzhou, Guangdong, Peoples R China
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80435-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [31] Adjuvant Chemotherapy for Resected Non-Small Cell Lung Cancer
    Wakelee, Heather
    Chhatwani, Laveena
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (03) : 198 - 203
  • [32] ADJUVANT CHEMOTHERAPY IN RESECTED STAGE IB-III NON SMALL CELL LUNG CANCER
    Zhang, B.
    Wong, H-L
    Gunawardana, D.
    Parente, P.
    de Boer, R.
    Barling, A.
    Antippa, P.
    Wong, R.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S32 - S32
  • [33] Feasibility Study of Adjuvant Chemotherapy of S-1 and Carboplatin for Completely Resected Non-Small Cell Lung Cancer
    Komazaki, Yoshitoshi
    Sakashita, Hiroyuki
    Furuiye, Masashi
    Fujie, Toshihide
    Tamaoka, Meiyo
    Sumi, Yuki
    Miyazaki, Yasunari
    Kojima, Katsuo
    Jin, Yasuto
    Inase, Naohiko
    CHEMOTHERAPY, 2013, 59 (01) : 35 - 41
  • [34] A Phase II Study of Adjuvant Chemotherapy with Docetaxel plus Nedaplatin for Completely Resected Non-Small Cell Lung Cancer
    Teramoto, K.
    Namura, Y.
    Hayashi, K.
    Ishida, K.
    Ueda, K.
    Okamoto, K.
    Kaku, R.
    Hori, T.
    Kawaguchi, Y.
    Igarashi, T.
    Hashimoto, M.
    Ohshio, Y.
    Kitamura, S.
    Motoishi, M.
    Suzumura, Y.
    Sawai, S.
    Hanaoka, J.
    Daigo, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1963 - S1964
  • [35] Adjuvant chemotherapy in completely resected stage III-N2 non-small cell lung cancer
    Wang, S.
    Ou, W.
    Sun, H.
    Yang, H.
    Ye, X.
    Fang, Q.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503
    Kubota, Kaoru
    Kunitoh, Hideo
    Seto, Takashi
    Shimada, Naoki
    Tsuboi, Masahiro
    Ohhira, Tatsuo
    Okamoto, Hiroaki
    Masuda, Noriyuki
    Maruyama, Riichiroh
    Shibuya, Masahiko
    Watanabe, Koshiro
    LUNG CANCER, 2020, 141 : 32 - 36
  • [37] Management of stage IIIA non-small cell lung cancer (NSCLC) role of the chemotherapy
    Baudoux, Nathalie
    Friedlaender, Alex
    Addeo, Alfredo
    CURRENT CHALLENGES IN THORACIC SURGERY, 2022, 4
  • [38] Carboplatin-Pemetrexed Adjuvant Chemotherapy in Resected Non-small Cell Lung Cancer (NSCLC): A Phase II Study
    Karapanagiotou, Eleni M.
    Boura, Paraskevi G.
    Papamichalis, George
    Konstantinou, Marios
    Sepsas, Evangellos
    Chamalakis, George
    Simsiris, Panagiotis
    Gkiozos, Ioannis
    Syrigos, Kostas N.
    ANTICANCER RESEARCH, 2009, 29 (10) : 4297 - 4301
  • [39] Adjuvant chemotherapy in completely resected non-small-cell lung cancer
    Pisters, KMW
    Le Chevalier, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) : 3270 - 3278
  • [40] PHASE II TRIAL OF ADJUVANT CHEMOTHERAPY WITH TRI-WEEKLY CARBOPLATIN PLUS DOCETAXEL IN PATIENTS WITH COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER: INTERIM ANALYSIS
    Uramoto, Hidetaka
    Nakanishi, Ryoichi
    Sugaya, Masakazu
    Uchiyama, Akihiko
    Inoue, Masaaki
    Iwata, Teruo
    Ebi, Noriyuki
    Hanagiri, Takeshi
    Tanaka, Fumihiro
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S475 - S475
12345